Editor's Note: Green and red arrows refer to intraday stock price movement.NEW YORK ( TheStreet) -- CHANGE IN RATINGS Amyris ( AMRS) upgraded at Morgan Stanley from Equal-weight to Overweight. $32 price target. Company continues to execute on its growth strategy. Cameron International ( CAM) upgraded at Credit Suisse from Neutral to Outperform. $73 price target. Very strong orders. EMC ( EMC) upgraded at Oppenheimer from Perform to Outperform. $32 price target. Stock is attractive, following a recent pullback. East West Bancorp ( EWBC - Get Report) upgraded at FBR from Market Perform to Outperform. $23 price target. Stock is attractively valued, following a recent pullback. Exelon ( EXC - Get Report) upgraded at UBS from Neutral to Buy. $50 price target. Cost synergy story and leverage to power recovery. Jazz Pharmaceuticals ( JAZZ - Get Report) upgraded at Jefferies to Buy. $52 price target. Estimates also upped, given recent Xyrem growth. Oceaneering International ( OII) downgraded at Credit Suisse from Outperform to Neutral. $48 price target. Central theses played out. Oil States ( OIS) upgraded at Credit Suisse from Neutral to Outperform. $110 price target. Stock should continue to deliver higher earnings. Rockwell Automation ( ROK) upgraded at Baird from Neutral to Outperform. $92 price target. Company can continue to deliver solid growth over the coming years. RadioShack ( RSH) upgraded at Goldman from Neutral to Buy. Company was also added to the Conviction Buy list. $18 price target. Company is improving its position in the wireless market. Vanguard Health ( VHS) rated new Overweight at JP Morgan. $22 price target. Company has attractive exposure to urban markets. Vodafone ( VOD) upgraded at UBS from Neutral to Buy. $31.05 price target. VZW dividend larger than expected. Vertex Pharmaceuticals ( VRTX - Get Report) upgraded at Citigroup from Hold to Buy. $60 price target. Incivek should not disappoint. End of report.
More from Stocks
When Earnings Are About 'Uncertainty' It's a Major Problem
I do think those watching for where we are in the cycle should be paying close attention to this earnings season.
Stocks Wobble as Investors Digest Mixed Boeing and Caterpillar Earnings
The Dow loses earlier momentum as a Boeing boost runs dry, while Texas Instruments' earnings miss pulls down the chip sector.
Schlumberger Is Basing and Poised for a Year-End Rally
SLB and other energy names have been out of favor for a long time but now I am seeing some light at the end of the tunnel.
How Investors Should Approach Nike and Under Armour After the CEO Shuffle
What's next for Under Armour and Nike after the CEO shuffle?
TD Ameritrade CEO: We'll 'Consider' Fractional Shares As Part of 'Roadmap'
TD Ameritrade's CEO weighs in on offering fractional shares, and how TD Ameritrade is making itself stand out in the crowd.